Your browser doesn't support javascript.
loading
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Shah, Bijal D; Ghobadi, Armin; Oluwole, Olalekan O; Logan, Aaron C; Boissel, Nicolas; Cassaday, Ryan D; Leguay, Thibaut; Bishop, Michael R; Topp, Max S; Tzachanis, Dimitrios; O'Dwyer, Kristen M; Arellano, Martha L; Lin, Yi; Baer, Maria R; Schiller, Gary J; Park, Jae H; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C; Wierda, William G; DeAngelo, Daniel J; Stiff, Patrick; Jeyakumar, Deepa; Feng, Chaoling; Dong, Jinghui; Shen, Tong; Milletti, Francesca; Rossi, John M; Vezan, Remus; Masouleh, Behzad Kharabi; Houot, Roch.
Afiliação
  • Shah BD; Moffitt Cancer Center, Tampa, FL, USA. Electronic address: bijal.shah@moffitt.org.
  • Ghobadi A; Washington University School of Medicine and Siteman Cancer Center, St Louis, MO, USA.
  • Oluwole OO; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Logan AC; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Boissel N; Hôpital Saint-Louis, Paris, France.
  • Cassaday RD; University of Washington School of Medicine, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Leguay T; Centre Hospitalier Universitaire de Bordeaux, Pessac, France.
  • Bishop MR; The University of Chicago Medicine, Chicago, IL, USA.
  • Topp MS; Universitätsklinikum Würzburg, Würzburg, Germany.
  • Tzachanis D; University of California, San Diego, La Jolla, CA, USA.
  • O'Dwyer KM; Wilmot Cancer Institute of University of Rochester, Rochester, NY, USA.
  • Arellano ML; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Lin Y; Mayo Clinic, Rochester, MN, USA.
  • Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Park JH; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Subklewe M; Ludwig-Maximilians-Universität München, Munich, Germany.
  • Abedi M; University of California-Davis Medical Center, Sacramento, CA, USA.
  • Minnema MC; University Medical Center Utrecht, Utrecht, Netherlands.
  • Wierda WG; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Stiff P; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
  • Jeyakumar D; University of California Irvine Medical Center, Irvine, CA, USA.
  • Feng C; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Dong J; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Shen T; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Milletti F; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Rossi JM; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Vezan R; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Masouleh BK; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Houot R; CHU Rennes, University of Rennes, INSERM U1236, EFS, Rennes, France.
Lancet ; 398(10299): 491-502, 2021 08 07.
Article em En | MEDLINE | ID: mdl-34097852
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunoterapia Adotiva / Receptores de Antígenos Quiméricos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunoterapia Adotiva / Receptores de Antígenos Quiméricos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article